Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Hypertension. 2010 Sep 7;56(5):942–949. doi: 10.1161/HYPERTENSIONAHA.110.156570

Figure 6.

Figure 6

Effect of ET-1 infusion (A–D) with or without concurrent treatment with ABT-627 (E–H) on glomerular and plasma sICAM-1 and MCP-1 concentrations. n=5–9 per group. *P<0.05 versus saline and †P<0.05 versus ET-1 alone.